| Title | Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination. | | Author(s) | Bikowski JB | | Institution | Bikowski Skin Care Center, Sewickley, PA 15143, USA. | | Source | J Drugs Dermatol 2005 Mar-Apr; 4(2):164-71. | | MeSH | Acne Vulgaris
Adolescent
Adult
Benzoyl Peroxide
Clindamycin
Double-Blind Method
Doxycycline
Drug Therapy, Combination
Female
Gels
Humans
Male
Naphthalenes
| | Abstract | This article will examine various clinical experiences with acne patients successfully treated with topical clindamycin 1% benzoyl peroxide 5% gel (Duac) alone and in combination with other acne treatments. Clindamycin 1% benzoyl peroxide 5%, the only once-daily prescription topical aqueous gel combining a benzoyl peroxide and an antibiotic, has demonstrated excellent tolerability and efficacy and is stable when used concomitantly with other therapies. A regimen of topical clindamycin 1% benzoyl peroxide 5% gel, oral doxycycline hyclate (Doryx), and adapalene gel (Differin) seems especially advantageous from a theoretical and practical perspective. Improvement is noted by means of photographic, physician, and/or patient assessments at baseline and follow-up visits. | | Language | eng | | Pub Type(s) | Clinical Trial
Journal Article
Randomized Controlled Trial
| | PubMed ID | 15776773 |
|
